]>
IRCT20190325043107N16 IRCT 2019-12-22 Tabriz University of Medical Sciences Prevention of deep vein thrombosis in pre-trochanteric hip fracture Comparison the Injectual Enoxaparin with Oral Rivaroxaban in DVT Prophylaxis of Patients with Pre-Trochanteric Hip Fracture 2020-01-05 anticipated 80 Complete https://irct.ir/trial/44128 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: All patients will be randomly assigned to one of the two groups of enoxaparin or rivaroxaban with the help of an online randomization list (www.randomizer.org). 3 Deep vein thrombosis. Intervention 1: Intervention group: in the intervention group, after surgery, they will receive 40 mg of enoxaparin subcutaneously for 30 days (one daily). The enoxaparin ampoule will be purchased from Iran Daroo Company ready and given by a nurse every day. Blood will be taken from the patient before the intervention and on the last day of the intervention and serum D-Dimer levels will be measured. Intervention 2: Control group: patients will be enrolled after random assignment. In the intervention group, after surgery, 10 mg rivaroxaban will be given orally for 30 days (one daily). Rivaroxaban tablets will be purchased from Iran Daroo Company and will be administered daily by a nurse. Blood will be taken from the patient before the intervention and on the last day of the intervention and serum D-Dimer levels will be measured. No - There is not a plan to make this available Justification or reason for not sharing IPD is No more information
public Mohammad Bazavar
Tabriz University of Medical Sciences, Azadi Ave
Tabriz Iran (Islamic Republic of) 5165665631 +98 41 3335 7310 Mbazavar@yahoo.com Tabriz University of Medical Sciences scientific Mohammad Bazavar
Tabriz University of Medical Sciences, Azadi Ave
Tabriz Iran (Islamic Republic of) 5165665631 +98 41 3335 7310 Mbazavar@yahoo.com Tabriz University of Medical Sciences Iran (Islamic Republic of) Presence of peri-trochanteric femur fracture 30 years 80 years Both Heparin sensitivity Endocarditis Liver disease Hematologic diseases I82.4 Acute embolism and thrombosis of deep veins of lower extremity Prevention Prevention Intervention group: in the intervention group, after surgery, they will receive 40 mg of enoxaparin subcutaneously for 30 days (one daily). The enoxaparin ampoule will be purchased from Iran Daroo Company ready and given by a nurse every day. Blood will be taken from the patient before the intervention and on the last day of the intervention and serum D-Dimer levels will be measured. Control group: patients will be enrolled after random assignment. In the intervention group, after surgery, 10 mg rivaroxaban will be given orally for 30 days (one daily). Rivaroxaban tablets will be purchased from Iran Daroo Company and will be administered daily by a nurse. Blood will be taken from the patient before the intervention and on the last day of the intervention and serum D-Dimer levels will be measured. Deep vein thrombosis. Timepoint: Once before the intervention and once at the end of the study (30 days later). Method of measurement: Take a blood test and check the level of D-Dimer in the blood. Tabriz University of Medical Sciences Approved 2019-12-09 Ethics committee of Tabriz University of Medical Sciences Tabriz University of Medical Sciences, Azadi Ave Tabriz East Azarbaijan Iran (Islamic Republic of)